Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13 - Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center @MDAndersonNews #pancreaticc...

Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13 - Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center @MDAndersonNews #pancreaticc...

User Photo
Cancer-News

5 months
36 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13

 

https://www.firstwordpharma.com/node/1731315

Up Next Autoplay
>